日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India

印度一家三级癌症中心关于一线奥希替尼治疗EGFR突变型非小细胞肺癌的真实世界经验

Tiwari, Atul; Singh, Ajay Kumar; Noronha, Vanita; Patil, Vijay M; Menon, Nandini; Shah, Minit J; Shah, Darshit; Jobanputra, Kunal; Trikha, Mehak; Ubharay, Ahmad; Yadav, Shashikant; Majumdar, Anuradha; Chandrani, Pratik; Kumar, Rajiv K; Pai, Trupti; Janu, Amit; Purandare, Nilendu; Prabhash, Kumar

Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India

印度真实世界数据显示,阿来替尼一线治疗ALK突变型肺癌的安全性和有效性

Singh, Ajaykumar; Noronha, Vanita; Patil, Vijay; Menon, Nandini; Kapoor, Akhil; Trikha, Mehak; Manmode, Sima; Kaushal, Rajiv; Pai, Trupti; Purandare, Nilendu; Janu, Amit; Majumdar, Anuradha; Ubharay, Ahmad Ashfaq Ahmad; Prabhash, Kumar